Sun marches ahead with its specialty pipeline, announces European approval for Tildra

In the last two months Sun Pharma has received approval for four drugs from its pipeline after a dry spell of nearly 2 years.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2OwcBJh
via IFTTT